Tag Archives: Technology

International Stem Cell Corporation, Through Its Subsidiary Lifeline Cell Technology, Announces the Launch and Sale of New Products into the Human Cell Research Market

International Stem Cell Corporation, announces that it has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology, (Walkersville, MD), leading to a 12-month average month-to-month revenue growth of 50%. ISCO, the parent company, is the first company to create human “parthenogenetic” stem cells from unfertilized eggs. Parthenogenetic stem cells not only solve ethical problems, but also promise to minimize immune-rejection by providing cells that can be immune-matched to large segments of the population.

These products represent milestone
Read More…

SpineSmith to Present at the 5th Annual Stem Cell Summit

Image via Wikipedia

Dr. Robert Johnson, MD, of Neurosurgical Associates of San Antonio, is presenting at the 5th Annual Stem Cell Summit in New York on February 16, 2010. Dr. Johnson will be presenting his most recent data proving the efficacy of point of care adult stem cell therapies in spine surgery. Point of care technology utilizes the patient’s own cells derived from bone marrow to inhibit bone growth in spinal fusion procedures. Dr. Johnson believes promoting cell therapy utilizing the patient’s own cells will change the future landscape of medicine.

“The use of autologous stem cells is revolutionizing
Read More…

Life Stem Genetics Announces Collaborative Agreement with American CryoStem

 

Life Stem Genetics announced today a strategic collaborative agreement with American CryoStem Corporation.

 

CRYO is a leading developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries.

 

Adipose tissue is an anatomical term for loose connective tissue (fat) composed of adipocytes (cells). It is used in LIFS stem cell procedures and currently is extracted via liposuction each time a patient has a treatment.

SANUWAVE’S PACE Shows Promise In Stimulating Autogenous Sources Of Progenitor/STEM Cells For Harvest And Re-Transplantation In Bone Tissue Engineering

SANUWAVE Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reported that scientific findings titled “Extracorporeal Shock Wave Stimulation of Osteoprogenitor Cells” were presented at the 2009 International Bone-Tissue-Engineering Congress (“Bone-Tec”) in Hannover, Germany, which was held October 9-11, 2009.

Dr. Myron Spector, PhD, Professor of Orthopaedic Surgery (Biomaterials) at Harvard Medical School, Director of Orthopaedic Research at Brigham and Women’s Hospital and Director of Tissue Engineering at VA Boston Healthcare System, was an invited guest speaker at the Conference. The
Read More…

Stem cells aim to space disease

Stem cells exposed to microgravity express different proteins than those grown in normal gravity, say Australian researchers (…)

Dr Burns, along with graduate researchers Elizabeth Blaber and Helder Marcal, used a NASA rotating-wall vessel to simulate microgravity, which is experienced by astronauts in low Earth orbit, to analyse its effect on human embryonic stem cells.
Stem cells are cells that have yet to differentiate into cells with specialised functions (…)

Associate Professor Ernst Wolvetang of the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland says while it’s difficult to judge the research prior to publication, it is a “novel
Read More…